Sort
21,281 grants matching “influenza”
Pandemic Influenza Translational Research and novel universal countermeasure development
$981,112Matthew Memoli · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Identification and validation of influenza host factors as therapeutic targets
$980,999David E Root · Broad Institute, Inc. · U01 · FY2009 · AI
Diagnostic Influenza RT-PCR Array
$980,513Darrell P Chandler · Akonni Biosystems, Inc. · R44 · FY2010 · AI
FROM GENOMIC SEQUENCES TO PROTEIN STRUCTURE/FUNCTION
$980,270University Of Md Biotechnology Institute · P01 · FY2002 · GM
Targeting the NS1 Protein for the Development of Influenza Virus Antivirals
$980,151Robert M Krug · University Of Texas At Austin · U01 · FY2009 · AI
SIMULTANEOUS SCREENING FOR A/H3N2, A/H1N1, A/H5N1 AND B INFLUENZA VIRUSES
$980,000Erica D Dawson · Indevr, Inc. · R44 · FY2013 · AI
Leadership Group for the Infectious Diseases Clinical Research Consortium (IDCRCLG)
$979,886David S Stephens · Emory University · UM1 · FY2020 · AI
Development of a Broad-Spectrum Inhibitor against Seasonal and Highly-Pathogenic Influenza Viruses
$979,627Richard K. Plemper · Georgia State University · R01 · FY2021 · AI
A single antiviral to treat multiple opportunistic infections
$978,771Stacy Remiszewski · Evrys Bio, Llc · R44 · FY2025 · AI
Novel Strategies to Clear Bacteria from the CF Lung
$977,764Saira Ahmad · Eldec Pharmaceuticals, Inc. · R44 · FY2023 · HL
Discovery of Bunyaviral Endonuclease Inhibitors for Anti Viral
$977,449Gai Liu · Microbiotix, Inc · R42 · FY2025 · AI
Clinic-Ready MACH-1 Gene Gun for delivery of a universal influenza DNA vaccine
$977,255Hannah Frizzell · Orlance, Inc. · R44 · FY2025 · AI
Systems Biology Approaches to Viral Pathogenesis and Immunity
$976,964Michael G Katze · Oregon Health & Science University · U54 · FY2012 · AI
MycoMEIA - Urine Diagnostic for Aspergillosis
$976,576Kieren A. Marr · Pearl Diagnostics, Inc. · R44 · FY2021 · AI
Enhanced Oral Vaccine Delivery Vehicle
$975,540Sean N Tucker · Vaxart, Inc. · R44 · FY2011 · AI
Efficacy of Antibiotics in Children with Acute Sinusitis: Which Subgroups Benefit?
$975,370Nader Shaikh · University Of Pittsburgh At Pittsburgh · U01 · FY2016 · AI
Efficacy of Antibiotics in Children with Acute Sinusitis: Which Subgroups Benefit?
$975,370Nader Shaikh · University Of Pittsburgh At Pittsburgh · U01 · FY2018 · AI
Efficacy of Antibiotics in Children with Acute Sinusitis: Which Subgroups Benefit?
$975,370Nader Shaikh · University Of Pittsburgh At Pittsburgh · U01 · FY2017 · AI
PANDAA for universal, pan-lineage molecular detection of Crimean-Congo Hemorrhagic Fever virus.
$975,023Iain James Macleod · Aldatu Biosciences, Inc. · R44 · FY2025 · AI
Avian Flu A/H5N1 Vaccine Development in Vietnam
$975,000Nguyen Van Thu · Company For Vaccine & Biol Prodtn No, 1 · U01 · FY2006 · CI
Prospective Multicenter Study of Bronchiolitis Admissions: Etiology & Disposition
$974,929Carlos A. Camargo · Massachusetts General Hospital · U01 · FY2007 · AI
SIMULTANEOUS SCREENING FOR A/H3N2, A/H1N1, A/H5N1 AND B INFLUENZA VIRUSES
$974,637Erica D Dawson · Indevr, Inc. · R44 · FY2012 · AI
NEBRASKA PANDEMIC INFLUENZA PUBLIC ENGAGEMENT DEMONSTRATION
$974,395Christine Newlon · Nebraska St Dept Of Health & Human Servs · U90 · FY2008 · TP
Task Order 4: The Interventional Agent Development Services Program
$973,748Sri International · N01 · FY2012 · AI
Collaborative Modeling for Assessment and Optimization in Public Health
$973,020Marc Lipsitch · Harvard School Of Public Health · U54 · FY2015 · GM